Omeros Corporation | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (49)

View All

Latest Posts

About This Stock More About This Stock
Omeros Derisked
Article By: Alan Robert Ross
Saturday, July 20, 2019 4:08 PM EDT
Omeros has recently reported progress that derisks the company. The fundamental risk reduction has not been reflected in the excessively discounted share price.
In this article: OMER
Read
Omeros' Path To OMS7211 Approval
Article By: Alan Robert Ross
Monday, May 14, 2018 2:09 PM EDT
OMS721 just was awarded FDA Breakthrough Therapy Designation for yet another disorder; to treat patients at significant risk of dying after Hematopoietic Stem Cell Transplant.
In this article: OMER
Read
Omeros Announces Positive Phase 2 Results For Its OMS721 Trial
Article By: Terry Chrisomalis
Tuesday, August 18, 2015 7:27 PM EDT
Shares of Omeros closed the day up 72% after announcing positive phase 2 results for its treatment of thrombotic microangiopathies.
In this article: OMER
Read
Wedbush Highlights Upcoming Catalysts In The Pharmaceutical Sector
Article By: TipRanks
Sunday, June 7, 2015 6:11 AM EDT
On June 2, Wedbush analyst Liana Moussatos published a list of upcoming catalysts for emerging pharmaceuticals, specifically for Intercept Pharmaceuticals Inc, Receptos Inc, and Omeros Corporation.
In this article: ICPT, RCPT, OMER
Read
PTCT Spinal Muscular Atrophy Program Enters Phase 1b/2a Trial; OMER Inhibits Thrombus Formation
Article By: BioMedReports
Thursday, November 20, 2014 6:37 AM EDT
PTC Therapeutics and Omeros each announce new study phase.
In this article: OMER, PTCT
Read
All Posts

Latest Tweets for $OMER

No tweets yet!

PARTNER HEADLINES

$OMER

Comments Status Updates
Omeros Derisked
Kurt Benson • 6/29/2020 5:43:43 PM

What's your take on $OMER now?

1 to 1 of 1 comments